The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 134, 9-18
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Prediction models need appropriate internal, internal–external, and external validationJournal of Clinical Epidemiology, 2016
- Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III MelanomaJournal of Clinical Oncology, 2012
- Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography CriteriaJournal of Clinical Oncology, 2011
- Age as a key factor influencing metastasizing patterns and disease‐specific survival after sentinel lymph node biopsy for cutaneous melanomaInternational Journal of Cancer, 2010
- Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph NodesJournal of Clinical Oncology, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma PatientsAnnals of Surgery, 2008
- Microscopic Tumor Burden in Sentinel Lymph Nodes Predicts Synchronous Nonsentinel Lymph Node Involvement in Patients With MelanomaJournal of Clinical Oncology, 2008
- Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institutionEuropean Journal of Surgical Oncology, 2008
- Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for MelanomaJournal of Clinical Oncology, 2004